newsfilter
← Latest News
PR Newswire·

MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering

MetaVia Inc. (Nasdaq: MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today...